In 2010, the aggregate profit margin for the firms in Chemical & Engineering News’ survey of the top 50 chemical companies was 11.4%, the highest profit margin in 15 years. Sales at the 49 firms showing similar year-over-year figures grew 25.3% to $857 billion in 2010. Operating profits for the 47 firms with similar year-over-year […]
Costco Wholesale and Beef Products are two companies that have opted to take action rather than wait for the US government to uphold its promise to strengthen consumers’ protection from E. coli. E. coli prevention previously concentrated on one prevalent strain of the bacteria, O157:H7. The US Department of Agriculture’s proposal for how to address […]
Despite drug R&D spending falling to a three-year low of $68 billion in 2010, pharmaceutical sales grew to a record $856 billion. Drug companies are spending 22% of global sales, of which only 5% come from products new to market over the past five years, on R&D. In 2010, 21 new molecular entities were introduced, […]
Renewable energy investments continued to grow in 2010, according to the latest “Global Trends in Renewable Energy Investment” report. In 2010, $211 billion was spent on renewable energy, an increase of almost a third due to stimulus funding, new guidelines, wind farm development and small-scale rooftop solar PV installation. Asset financing grew 19% to $128 […]
US import lines of FDA-regulated products grew annually by 13%, from 7.9 million in 2002 to 18.5 million in 2009, according to the FDA’s “Pathway to Global Product Safety and Quality” report. Between 2002 and 2009, the compound annual growth rates for imported FDA-regulated foods, drugs, medical devices, veterinary products and biologics were 9.5%, 12.9%, […]
For the second half of 2011, sales growth for the global chemicals market is expected to be solid, but volume growth will be milder, according to Deloitte Touche Tohmatsu’s “Compass 2011: Global Chemicals Sector Midyear Outlook.” Sales have been on the rise due to steeper prices and growth in developing markets. In 2010, Asia Pacific […]
Biomarkers can help indicate if people are likely to develop a disease and how they will respond to treatment, but the connection may be overstated, according to a recent analysis by John Ioannidis and Orestis Panagiotou. Their paper, published in the June 1 issue of the Journal of the American Medical Association (JAMA), examined 35 […]
Two of the eight chemicals added to the 12th “Report on Carcinogens” are used every day. The report, from the NIH’s National Toxicology Program, cited repeated exposure during manufacturing as much riskier than normal exposure. Consumers were advised not to come in contact with either formaldehyde, a known carcinogen, or styrene, a probable carcinogen. Questionable […]
Biotech companies in the US, Europe and Canada raised $25.0 billion in funding last year, a 7.8% increase. However, 83% of this funding went to only 20% of the companies, and financings accounted for 45% of funding, indicating that large, mature companies benefited the most. Less venture capital funding was available up front and was […]
A survey, with a 71% response rate, of 78 small molecule drug discovery centers located at US universities or nonprofit research organizations found that cancer and infectious disease were the most prevalent therapeutic areas, with 86% and 71% of respondents, respectively, including these areas among their projects. The top three target-class focuses were phenotypic assays […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
